A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer
Clinical trial NCT02560974 · COMPLETED
Trial details
- NCT number
- NCT02560974
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2012-11-01
- Enrollment
- 1035
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.